Protection from Endogenous Perforin: Glycans and the C Terminus Regulate Exocytic Trafficking in Cytotoxic Lymphocytes

Immunity

Volumn 34, Issue 6, 2011, Pages 879-892

  Brennan, Amelia J ^a,b   Chia, Jenny ^a   Browne, Kylie A ^a   Ciccone, Annette ^a   Ellis, Sarah ^a   Lopez, Jamie A ^a,b   Susanto, Olivia ^a   Verschoor, Sandra ^a   Yagita, Hideo ^c   Whisstock, James C ^d   Trapani, Joseph A ^a,b   Voskoboinik, Ilia ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; GLYCAN; PERFORIN; TRYPTOPHAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MIGRATION; CELL SURVIVAL; CELL TRANSPORT; CONTROLLED STUDY; CYTOTOXICITY; ENDOPLASMIC RETICULUM; EXOCYTOSIS; GLYCOSYLATION; GOLGI COMPLEX; HOST CELL; HUMAN; HUMAN CELL; LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT; SECRETORY GRANULE;

ANIMALS; AUTOLYSIS; CELL LINE; CELL MOVEMENT; ENDOPLASMIC RETICULUM; EXOCYTOSIS; GLYCOSYLATION; HUMANS; MICE; MICE, KNOCKOUT; MUTATION; PERFORIN; POLYSACCHARIDES; RATS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 79959356948     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2011.04.007     Document Type: Article

References (45)

1. Aebi M., Bernasconi R., Clerc S., Molinari M. N-glycan structures: Recognition and processing in the ER. Trends Biochem. Sci. 2010, 35:74-82.
2. Baran K., Dunstone M., Chia J., Ciccone A., Browne K.A., Clarke C.J., Lukoyanova N., Saibil H., Whisstock J.C., Voskoboinik I., Trapani J.A. The molecular basis for perforin oligomerization and transmembrane pore assembly. Immunity 2009, 30:684-695.
3. Barry M., Bleackley R.C. Cytotoxic T lymphocytes: All roads lead to death. Nat. Rev. Immunol. 2002, 2:401-409.
4. Bird C.H., Sutton V.R., Sun J., Hirst C.E., Novak A., Kumar S., Trapani J.A., Bird P.I. Selective regulation of apoptosis: The cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Mol. Cell. Biol. 1998, 18:6387-6398.
5. Bolitho P., Voskoboinik I., Trapani J.A., Smyth M.J. Apoptosis induced by the lymphocyte effector molecule perforin. Curr. Opin. Immunol. 2007, 19:339-347.
6. Brennan A.J., Chia J., Trapani J.A., Voskoboinik I. Perforin deficiency and susceptibility to cancer. Cell Death Differ. 2010, 17:607-615.
7. Chia J., Yeo K.P., Whisstock J.C., Dunstone M.A., Trapani J.A., Voskoboinik I. Temperature sensitivity of human perforin mutants unmasks subtotal loss of cytotoxicity, delayed FHL, and a predisposition to cancer. Proc. Natl. Acad. Sci. USA 2009, 106:9809-9814.
8. Cooper A.A., Gitler A.D., Cashikar A., Haynes C.M., Hill K.J., Bhullar B., Liu K., Xu K., Strathearn K.E., Liu F., et al. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 2006, 313:324-328.
9. D'Angelo M.E., Bird P.I., Peters C., Reinheckel T., Trapani J.A., Sutton V.R. Cathepsin H is an additional convertase of pro-granzyme B. J. Biol. Chem. 2010, 285:20514-20519.
10. Dennert G., Podack E.R. Cytolysis by H-2-specific T killer cells. Assembly of tubular complexes on target membranes. J. Exp. Med. 1983, 157:1483-1495.
11. Griffiths G.M., Isaaz S. Granzymes A and B are targeted to the lytic granules of lymphocytes by the mannose-6-phosphate receptor. J. Cell Biol. 1993, 120:885-896.
12. Helenius A., Aebi M. Roles of N-linked glycans in the endoplasmic reticulum. Annu. Rev. Biochem. 2004, 73:1019-1049.
13. Henkart P.A., Yue C.C., Yang J., Rosenberg S.A. Cytolytic and biochemical properties of cytoplasmic granules of murine lymphokine-activated killer cells. J. Immunol. 1986, 137:2611-2617.
14. Henter J.I., Horne A., Aricó M., Egeler R.M., Filipovich A.H., Imashuku S., Ladisch S., McClain K., Webb D., Winiarski J., Janka G. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer 2007, 48:124-131.
15. Hernandez-Pigeon H., Jean C., Charruyer A., Haure M.J., Titeux M., Tonasso L., Quillet-Mary A., Baudouin C., Charveron M., Laurent G. Human keratinocytes acquire cellular cytotoxicity under UV-B irradiation. Implication of granzyme B and perforin. J. Biol. Chem. 2006, 281:13525-13532.
16. Hernandez-Pigeon H., Jean C., Charruyer A., Haure M.J., Baudouin C., Charveron M., Quillet-Mary A., Laurent G. UVA induces granzyme B in human keratinocytes through MIF: Implication in extracellular matrix remodeling. J. Biol. Chem. 2007, 282:8157-8164.
17. Hirst C.E., Buzza M.S., Bird C.H., Warren H.S., Cameron P.U., Zhang M., Ashton-Rickardt P.G., Bird P.I. The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency. J. Immunol. 2003, 170:805-815.
18. Kägi D., Ledermann B., Bürki K., Seiler P., Odermatt B., Olsen K.J., Podack E.R., Zinkernagel R.M., Hengartner H. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994, 369:31-37.
19. Katano H., Cohen J.I. Perforin and lymphohistiocytic proliferative disorders. Br. J. Haematol. 2005, 128:739-750.
20. Kawasaki A., Shinkai Y., Kuwana Y., Furuya A., Iigo Y., Hanai N., Itoh S., Yagita H., Okumura K. Perforin, a pore-forming protein detectable by monoclonal antibodies, is a functional marker for killer cells. Int. Immunol. 1990, 2:677-684.
21. Klausner R.D., Donaldson J.G., Lippincott-Schwartz J. Brefeldin A: Insights into the control of membrane traffic and organelle structure. J. Cell Biol. 1992, 116:1071-1080.
22. Law R.H., Lukoyanova N., Voskoboinik I., Caradoc-Davies T.T., Baran K., Dunstone M.A., D'Angelo M.E., Orlova E.V., Coulibaly F., Verschoor S., et al. The structural basis for membrane binding and pore formation by lymphocyte perforin. Nature 2010, 468:447-451.
23. Pham C.T., Ley T.J. Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. Proc. Natl. Acad. Sci. USA 1999, 96:8627-8632.
24. Pipkin M.E., Ljutic B., Cruz-Guilloty F., Nouzova M., Rao A., Zúñiga-Pflücker J.C., Lichtenheld M.G. Chromosome transfer activates and delineates a locus control region for perforin. Immunity 2007, 26:29-41.
25. Podack E.R., Dennert G. Assembly of two types of tubules with putative cytolytic function by cloned natural killer cells. Nature 1983, 302:442-445.
26. Podack E.R., Young J.D., Cohn Z.A. Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules. Proc. Natl. Acad. Sci. USA 1985, 82:8629-8633.
27. Rodriguez-Boulan E., Paskiet K.T., Salas P.J., Bard E. Intracellular transport of influenza virus hemagglutinin to the apical surface of Madin-Darby canine kidney cells. J. Cell Biol. 1984, 98:308-319.
28. Rosado C.J., Buckle A.M., Law R.H., Butcher R.E., Kan W.T., Bird C.H., Ung K., Browne K.A., Baran K., Bashtannyk-Puhalovich T.A., et al. A common fold mediates vertebrate defense and bacterial attack. Science 2007, 317:1548-1551.
29. Rosado C.J., Kondos S., Bull T.E., Kuiper M.J., Law R.H., Buckle A.M., Voskoboinik I., Bird P.I., Trapani J.A., Whisstock J.C., Dunstone M.A. The MACPF/CDC family of pore-forming toxins. Cell. Microbiol. 2008, 10:1765-1774. Published online June 29, 2008.
30. Saraste J., Kuismanen E. Pre- and post-Golgi vacuoles operate in the transport of Semliki Forest virus membrane glycoproteins to the cell surface. Cell 1984, 38:535-549.
31. Saraste J., Kuismanen E. Pathways of protein sorting and membrane traffic between the rough endoplasmic reticulum and the Golgi complex. Semin. Cell Biol. 1992, 3:343-355.
32. Smyth M.J., McGuire M.J., Thia K.Y. Expression of recombinant human granzyme B. A processing and activation role for dipeptidyl peptidase I. J. Immunol. 1995, 154:6299-6305.
33. Smyth M.J., Thia K.Y., Street S.E., MacGregor D., Godfrey D.I., Trapani J.A. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J. Exp. Med. 2000, 192:755-760.
34. Stepp S.E., Dufourcq-Lagelouse R., Le Deist F., Bhawan S., Certain S., Mathew P.A., Henter J.I., Bennett M., Fischer A., de Saint Basile G., Kumar V. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999, 286:1957-1959.
35. Street S.E., Trapani J.A., MacGregor D., Smyth M.J. Suppression of lymphoma and epithelial malignancies effected by interferon gamma. J. Exp. Med. 2002, 196:129-134.
36. Suck G., Branch D.R., Smyth M.J., Miller R.G., Vergidis J., Fahim S., Keating A. KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity. Exp. Hematol. 2005, 33:1160-1171.
37. Sutton V.R., Wowk M.E., Cancilla M., Trapani J.A. Caspase activation by granzyme B is indirect, and caspase autoprocessing requires the release of proapoptotic mitochondrial factors. Immunity 2003, 18:319-329.
38. Sutton V.R., Waterhouse N.J., Baran K., Browne K., Voskoboinik I., Trapani J.A. Measuring cell death mediated by cytotoxic lymphocytes or their granule effector molecules. Methods 2008, 44:241-249.
39. Thiery J., Keefe D., Saffarian S., Martinvalet D., Walch M., Boucrot E., Kirchhausen T., Lieberman J. Perforin activates clathrin- and dynamin-dependent endocytosis, which is required for plasma membrane repair and delivery of granzyme B for granzyme-mediated apoptosis. Blood 2010, 115:1582-1593.
40. Trapani J.A., Smyth M.J. Functional significance of the perforin/granzyme cell death pathway. Nat. Rev. Immunol. 2002, 2:735-747.
41. Uellner R., Zvelebil M.J., Hopkins J., Jones J., MacDougall L.K., Morgan B.P., Podack E., Waterfield M.D., Griffiths G.M. Perforin is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid-binding C2 domain. EMBO J. 1997, 16:7287-7296.
42. Voskoboinik I., Thia M.C., De Bono A., Browne K., Cretney E., Jackson J.T., Darcy P.K., Jane S.M., Smyth M.J., Trapani J.A. The functional basis for hemophagocytic lymphohistiocytosis in a patient with co-inherited missense mutations in the perforin (PFN1) gene. J. Exp. Med. 2004, 200:811-816.
43. Voskoboinik I., Thia M.C., Fletcher J., Ciccone A., Browne K., Smyth M.J., Trapani J.A. Calcium-dependent plasma membrane binding and cell lysis by perforin are mediated through its C2 domain: A critical role for aspartate residues 429, 435, 483, and 485 but not 491. J. Biol. Chem. 2005, 280:8426-8434.
44. Voskoboinik I., Sutton V.R., Ciccone A., House C.M., Chia J., Darcy P.K., Yagita H., Trapani J.A. Perforin activity and immune homeostasis: The common A91V polymorphism in perforin results in both presynaptic and postsynaptic defects in function. Blood 2007, 110:1184-1190.
45. Yagita M., Huang C.L., Umehara H., Matsuo Y., Tabata R., Miyake M., Konaka Y., Takatsuki K. A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation. Leukemia 2000, 14:922-930.